Gene therapy | Cancer in general | Cancer Research UK

Gene therapy is a cancer treatment that is still in the early stages of research.

Genes are coded messages that tell cells how to make proteins. Proteins are the molecules that control the way cells behave. Our genes decide what we look like and how our body works.We have many thousands of separate genes.

Genes are made ofDNAand they are in the nucleus of the cell. The nucleus is the cell's control centre.Genes are grouped together to make chromosomes. We inherit half our chromosomes from our mother and half from our father.

Cancer cells are different from normal cells. They have changes (called faults or mutations) in several of their genes which make them divide too often and form a tumour. The genes that are damaged mightbe:

Many gene changes thatmake a cell become cancerous are caused by environmental or lifestyle factors. A small numberof people haveinherited faulty genes that increase their risk of particular types of cancer.

Gene therapy is a type of treatment which uses genes to treat illnesses. Researchers have been developing differenttypes of gene therapyto treat cancer.

The ideas for these new treatments have come about because we are beginning to understand how cancer cells are different from normal cells. It is stillearly days for this type of treatment. Some of these treatments are being looked at in clinical trials. Otherscan now be used for some people with types of cancer such as melanoma skin cancer.

Getting genes into cancer cells is one of the most difficult aspects of gene therapy. Researchers are working on finding new and better ways of doing this. The gene is usually taken into the cancer cell by a carrier called a vector.

The most common types of carrier used in gene therapy are viruses because they can enter cells and deliver genetic material. The viruses have been changed so that they cannot cause serious disease but they may still cause mild, flu-like symptoms.

Some viruses have been changed in the laboratory so that they target cancer cells and not healthy cells. So they only carry the gene into cancer cells.

Researchers are testing other types of carrier such as inactivated bacteria.

Researchers are looking at different ways of using gene therapy:

Some types of gene therapy aim to boost the body's natural ability to attack cancer cells. Ourimmune systemhas cells that recognise and kill harmful things that can cause disease, such as cancer cells.

There are many different types of immune cell. Some of them produce proteins that encourage other immune cells to destroy cancer cells. Some types of therapy add genes to a patient's immune cells. Thismakes them better at finding or destroying particular types of cancer.

There are a few trials using this type of gene therapy in the UK.

Some gene therapies put genes into cancer cells to make the cells more sensitive to particular treatments. The aim is to make treatments,such as chemotherapy or radiotherapy, work better.

Some types of gene therapy deliver genes into the cancer cells that allow the cells to change drugs from an inactive form to an active form. The inactive form of the drug is called a pro drug.

First of all you have treatment with thecarrier containing the gene, then you havethe pro drug.The pro drug circulates in the body and doesn't harm normal cells. But when it reaches the cancer cells, it is activated by the gene and the drug kills the cancer cells.

Some gene therapies block processes that cancer cells use to survive. For example, most cells in the body are programmed to die if their DNA is damaged beyond repair. This is called programmed cell death or apoptosis. Cancer cells block this process so they don't die even when they are supposed to.

Some gene therapy strategies aim to reverse this blockage. Researchers are looking at whetherthese new types of treatment will make the cancer cells die.

Some viruses infect and kill cells. Researchers are working on ways to change these viruses so they only target and kill cancer cells, leaving healthy cells alone.

This sort of treatment uses the viruses to kill cancer cells directly rather than to deliver genes. So it is not cancer gene therapy in the true sense of the word. But doctors sometimes refer to it as gene therapy.

An example is a drug called T-VEC (talimogene laherparepvec), also known as Imlygic. It uses a strain of the cold sore virus (herpes simplex virus) that has been changed by altering the genes that tell the virus how to behave. It tells the virus to destroy the cancer cells and ignore the healthy cells.

T-VEC is now available as a treatment for melanoma skin cancer. It can be used to treat some people with melanomawhose cancer cannot be removed with surgery. It is also being looked at in trials for head and neck cancer. You have T-VEC as an injection directly into the melanoma or head and neck cancer.

Use the tabs along the top to look at recruiting, closed and results.

Follow this link:

Gene therapy | Cancer in general | Cancer Research UK

How Does Gene Therapy Work?

Scientists have promised that gene therapy will be the next big leap for medicine. It's a term that's tossed about regularly, but what is it exactly? Trace shows us how scientists can change your very genetic code.

Read More:

How does gene therapy work?http://ghr.nlm.nih.gov/handbook/thera..."Gene therapy is designed to introduce genetic material into cells to compensate for abnormal genes or to make a beneficial protein. If a mutated gene causes a necessary protein to be faulty or missing, gene therapy may be able to introduce a normal copy of the gene to restore the function of the protein."

Gene therapy trial 'cures children'http://www.bbc.co.uk/news/health-2326..."A disease which robs children of the ability to walk and talk has been cured by pioneering gene therapy to correct errors in their DNA, say doctors."

Gene therapy cures diabetic dogshttp://www.newscientist.com/article/d..."Five diabetic beagles no longer needed insulin injections after being given two extra genes, with two of them still alive more than four years later."

Gene Therapy for Cancer: Questions and Answershttp://www.cancer.gov/cancertopics/fa..."Gene therapy is an experimental treatment that involves introducing genetic material into a person's cells to fight or prevent disease."

How does gene therapy work?http://www.scientificamerican.com/art..."Gene therapy is the addition of new genes to a patient's cells to replace missing or malfunctioning genes. Researchers typically do this using a virus to carry the genetic cargo into cells, because that's what viruses evolved to do with their own genetic material."

Gene therapy cures leukaemia in eight dayshttp://www.newscientist.com/article/m...eight-days.htmlWITHIN just eight days of starting a novel gene therapy, David Aponte's "incurable" leukaemia had vanished. For four other patients, the same happened within eight weeks, although one later died from a blood clot unrelated to the treatment, and another after relapsing.

Cell Therapy Shows Promise for Acute Type of Leukemiahttp://www.nytimes.com/2013/03/21/hea..."A treatment that genetically alters a patient's own immune cells to fight cancer has, for the first time, produced remissions in adults with an acute leukemia that is usually lethal, researchers are reporting."

Watch More:Tricking the Immune Systemhttp://www.youtube.com/watch?v=Kr_HRl...Babies with 3 Parents?!http://www.youtube.com/watch?v=jQxsW_...Pick Your Poison: Cyanidehttp://www.youtube.com/watch?v=JDBrdE...____________________

DNews is dedicated to satisfying your curiosity and to bringing you mind-bending stories & perspectives you won't find anywhere else! New videos twice daily.

Watch More DNews on TestTube http://testtube.com/dnews

Subscribe now! http://www.youtube.com/subscription_c...

DNews on Twitter http://twitter.com/dnews

Anthony Carboni on Twitter http://twitter.com/acarboni

Laci Green on Twitter http://twitter.com/gogreen18

Trace Dominguez on Twitter http://twitter.com/trace501

DNews on Facebook http://facebook.com/dnews

DNews on Google+ http://gplus.to/dnews

Discovery News http://discoverynews.com

See the rest here:

How Does Gene Therapy Work?

Gene Therapy for Pediatric Diseases | DNA Therapy – Dana …

Gene therapy delivers DNAinto a patients cells to replace faulty or missing genes or adds new genes in an attempt to cure diseases or to make changes so the body is better able tofight off disease. The DNA for a gene or genes is carried into a patientscells by a delivery vehicle called a vector, typically a specially engineeredvirus. The vector then inserts the gene(s) into the cells' DNA.

Although gene therapy is relativelynew and often still considered experimental, it can provide a cure for life-threateningdiseases that dont respond well to other therapies (includingimmunodeficiencies, metabolic disorders, and relapsed cancers) and for acuteconditions that currently rely on complex and expensive life-long medicationand management (such as sickle cell disease and hemophilia).

CAR T-Cell Therapy for Relapsed Acute Lymphoblastic Leukemia (ALL)

Dana-Farber/Boston Childrens is a certified treatment center for providing the recently-FDA-approved CAR T-cell therapy called KYMRIAH for relapsed B-cell acute lymphoblastic leukemia (ALL). This promising new treatment entails genetic engineering of the patients own T-cells to increase targeting of a specific leukemia protein and then accelerate killing of the target. After modification, they are returned to the patient via IV where they can immediately begin destroying circulating cancer cells.

For more information about CAR T-cell therapy, contact our gene therapy program.

Our Gene Therapy Clinical Trials

Learn more about our gene therapy clinical trials.

Dana-Farber/BostonChildrens has one the most extensive and long-running pediatric gene therapyprograms in the world. Since 2010, wehave treated 36 patients from 11 countries through eight gene therapy clinicaltrials.

Why choose Dana-Farber/BostonChildrens:

Learn more

Read more:

Gene Therapy for Pediatric Diseases | DNA Therapy - Dana ...

Gene Therapy and Children – KidsHealth

Gene therapy carries the promise of cures for many diseases and for types of medical treatment that didn't seem possible until recently. With its potential to eliminate and prevent hereditary diseases such as cystic fibrosis and hemophilia and its use as a possible cure for heart disease, AIDS, and cancer, gene therapy is a potential medical miracle-worker.

But what about gene therapy for children? There's a fair amount of risk involved, so thus far only seriously ill kids or those with illnesses that can't be cured by standard medical treatments have been involved in clinical trials using gene therapy.

As those studies continue, gene therapy may soon offer hope for children with serious illnesses that don't respond to conventional therapies.

Our genes help make us unique. Inherited from our parents, they go far in determining our physical traits like eye color and the color and texture of our hair. They also determine things like whether babies will be male or female, the amount of oxygen blood can carry, and the likelihood of getting certain diseases.

Genes are composed of strands of a molecule called DNA and are located in single file within the chromosomes. The genetic message is encoded by the building blocks of the DNA, which are called nucleotides. Approximately 3 billion pairs of nucleotides are in the chromosomes of a human cell, and each person's genetic makeup has a unique sequence of nucleotides. This is mainly what makes us different from one another.

Scientists believe that every human has about 25,000 genes per cell. A mutation, or change, in any one of these genes can result in a disease, physical disability, or shortened life span. These mutations can be passed from one generation to another, inherited just like a mother's curly hair or a father's brown eyes. Mutations also can occur spontaneously in some cases, without having been passed on by a parent. With gene therapy, the treatment or elimination of inherited diseases or physical conditions due to these mutations could become a reality.

Gene therapy involves the manipulation of genes to fight or prevent diseases. Put simply, it introduces a "good" gene into a person who has a disease caused by a "bad" gene.

The two forms of gene therapy are:

Currently, gene therapy is done only through clinical trials, which often take years to complete. After new drugs or procedures are tested in laboratories, clinical trials are conducted with human patients under strictly controlled circumstances. Such trials usually last 2 to 4 years and go through several phases of research. In the United States, the U.S. Food and Drug Administration (FDA) must then approve the new therapy for the marketplace, which can take another 2 years.

The most active research being done in gene therapy for kids has been for genetic disorders (like cystic fibrosis). Other gene therapy trials involve children with severe immunodeficiencies, such as adenosine deaminase (ADA) deficiency (a rare genetic disease that makes kids prone to serious infection), sickle cell anemia, thalassemia, hemophilia, and those with familial hypercholesterolemia (extremely high levels of serum cholesterol).

Gene therapy does have risks and limitations. The viruses and other agents used to deliver the "good" genes can affect more than the cells for which they're intended. If a gene is added to DNA, it could be put in the wrong place, which could potentially cause cancer or other damage.

Genes also can be "overexpressed," meaning they can drive the production of so much of a protein that they can be harmful. Another risk is that a virus introduced into one person could be transmitted to others or into the environment.

Gene therapy trials in children present an ethical dilemma, according to some gene therapy experts. Kids with an altered gene may have mild or severe effects and the severity often can't be determined in infants. So just because some kids appear to have a genetic problem doesn't mean they'll be substantially affected by it, but they'll have to live with the knowledge of that problem.

Kids could be tested for disorders if there is a medical treatment or a lifestyle change that could be beneficial or if knowing they don't carry the gene reduces the medical surveillance needed. For example, finding out a child doesn't carry the gene for a disorder that runs in the family might mean that he or she doesn't have to undergo yearly screenings or other regular exams.

To cure genetic diseases, scientists must first determine which gene or set of genes causes each disease. The Human Genome Project and other international efforts have completed the initial work of sequencing and mapping virtually all of the 25,000 genes in the human cell. This research will provide new strategies to diagnose, treat, cure, and possibly prevent human diseases.

Although this information will help scientists determine the genetic basis of many diseases, it will be a long time before diseases actually can be treated through gene therapy.

Gene therapy's potential to revolutionize medicine in the future is exciting, and hopes are high for its role in ;curing and preventing childhood diseases. One day it may be possible to treat an unborn child for a genetic disease even before symptoms appear.

Scientists hope that the human genome mapping will help lead to cures for many diseases and that successful clinical trials will create new opportunities. For now, however, it's a wait-and-see situation, calling for cautious optimism./p>

Date reviewed: April 2014

See the rest here:

Gene Therapy and Children - KidsHealth

What is Gene Therapy? – Dana-Farber/Boston Children’s …

Gene therapy is a technique throughwhich genes are added or replaced to treat or prevent disease.

Our genes, which hold the code for all of our body's functions, aremade of DNA. Damage to DNA, such as a mutation, is an underlying cause of thegenetic defects that lead to cancers, blood disorders, and other conditions.Gene therapy delivers DNA into a patients cells to replace faulty or missinggenes or add new genes in an attempt to cure cancer or make changes so thebody is better able to fight off disease.

Scientists are investigating a number of different ways to do this:

How does gene therapy deliver new genes into cells?

With gene therapy, the DNA for the new or corrected gene or genes iscarried into a patients cells by a delivery vehicle called a vector, typicallya specially engineered virus. The vector then inserts the gene(s) into thecells' DNA.

For patients, the process for delivering genes to cells is fairlysimple.

View gene therapy video:

...or click to see an image of the gene therapy process:

Learn more

Visit link:

What is Gene Therapy? - Dana-Farber/Boston Children's ...

Gene Therapy Archives | Genetic Literacy Project

Hundreds of clinical trials are underway studying the technologys potential use in a wide range of genetic disorders, cancer and HIV/AIDS. There is some debate over whether or not the US already has approved its first gene therapy treatment.

In August 2017, the Food and Drug Administration (FDA) approved a cancer therapya CAR-T treatment marketed as Kymriahthat uses a patients own T cells and is a variation of the gene therapy that is being developed to treat single-gene diseases. The T cells are extracted and genetically altered so that they have a new gene that codes for a protein, known as a chimeric antigen receptor (CAR), that is a hybrid of two immune system proteins. One part guides the cells to the cancer cell targets and the other alerts the immune system. The cells, programmed to target and kill leukemia cells, are then injected back into the patient. Another CAR-T treatment, marketed as Yescarta, was approved for adults with aggressive forms of non-Hodgkins lymphoma in October 2017.

Some in the scientific community have pushed back against the idea of calling Kymriah or Yescarta true gene therapies, since they dont actually repair or replace a deficient gene. Instead, they say the most likely candidate to gain the first US approval is Luxturna, a one-time treatment that targets a rare, inherited form of blindness. A key committee of independent experts voted unanimously in October 2017 to recommend approval by the FDA for the treatment developed by Spark Therapeutics. The FDA is not bound by the panels decision, though the agency traditionally acts on its recommendations.

Hundreds of research studies (clinical trials) are underway to test gene therapies as treatments for genetic conditions, cancer and HIV/AIDS. ClinicalTrials.gov, a service of the National Institutes of Health, provides easy access to information about clinical trials. There is also a list of gene therapy clinical trials that are accepting (or will accept) participants. Among the studies and research:

See the article here:

Gene Therapy Archives | Genetic Literacy Project

Gene Therapy | Voyager Therapeutics

The time is right for gene therapy.

Over the last decade, adeno-associated virus (AAV) has emerged as a highly promising and attractive approach to gene therapy. AAV is a common, naturally occurring virus that has been shown to be a well-toleratedand effective gene therapy delivery vehicle in clinical trials. Advances in AAV vector design and related dosing techniques that enable widespread gene delivery in the brain and spinal cord have made AAV particularly well-suited for the treatment of neurological diseases. Since the targeted cells in the central nervous system (CNS) are long-lived, non-dividing neurons, treatments delivered in a single dose could generate long-lasting, or even lifelong, benefits. More than eight years of durable expression has been seen in the human brain following treatment with an AAV vector.

Importantly, improvements in related technology and approaches have made AAV production more easily scalable and efficient to meet clinical and commercial requirements. Voyager diligently selects and optimizes AAV vectors that are best suited for each program. We continue to invest to advance the science and technology around the three key elements of AAV vectors: capsid, promoter and transgene. We also systematically develop and optimize delivery techniques that are best suited for a particular disease.

Members of our team have co-discovered many of the known naturally occurring AAV capsids, which are the outer viral protein shells that enclose the target gene or micro RNA cassette, and have also created promising genetically engineered AAV capsids. We have efforts underway to genetically engineer capsids to yield vectors with desirable properties, such as enhanced tissue specificity and improved delivery of genes to the brain and spinal cord.Efforts are also underway at Voyager to optimize novel AAV capsids that demonstrate enhanced blood-brain barrier penetration for the potential treatment of CNS diseases following systemic administration of the AAV gene therapy vector.

We then design the vector genome, or payload, that we intend to deliver as a therapeutic, as in the case of our Friedreichs ataxia program, or silence or knockdown, as in the case of our ALS and Huntingtons disease programs.

Identifying the optimal route of administration and delivery parameters, such as infusion volume, flow rate, vector concentration and dose and formulation for a specific disease are critical to achieving safe and effective levels of gene expression in the targeted region of the CNS. For Voyagers current pipeline programs, we are pursuing a surgical approach for direct injection into a targeted region of the brain, coupled with real-time MRI in the case of our advanced Parkinsons disease and Huntingtons disease programs, or injection into the cerebrospinal fluid for broader delivery to the cells within and surrounding the spinal cord for our ALS and Friedreichs ataxia programs.

Led by pioneers in AAV gene therapy and neuroscience, we are deeply committed to developing gene therapies for severe neurological diseases that have the potential to positively impact the lives of people living with these diseases. For more information about how we engage with patients and the advocacy community, please visit our patients and caregivers page.

Originally posted here:

Gene Therapy | Voyager Therapeutics

Gene-Therapy – Experimental Mesothelioma Treatment

All types of cancer cells appear to have at least one essential thing in common: They have faulty genes. At the center of every cell in our bodies, there is a nucleus containing thousands of genes made of DNA. Genes are coded instructions for making proteins, the molecules that control how cells work.

A cell with healthy DNA will perform its function in the body, create new cells as needed and destroy itself when it is damaged beyond repair. However, when a carcinogen such as asbestos damages the DNA in a cell, it may cause the cell to grow and divide out of control, leading to cancer.

Many researchers believe that just as faulty genes are the key to cancer formation, modified genes may be the key to cancer treatment. Mesothelioma researchers are hopeful that gene therapy will bring us closer to a cure for mesothelioma.

Gene therapy is a broad category that refers to several emerging treatment approaches involving the novel science of genetic modification. It wasnt until recently in 2017 that the U.S. Food and Drug Administration (FDA) approved a gene-therapy-based cancer treatment for the first time.

So far, most gene therapies tested for mesothelioma have shown either limited effectiveness or severe side effects and risks of complications. For this reason, all types of gene therapy for mesothelioma are experimental and only available through clinical trials.

The most obvious gene therapy approach is to fix the genetic fault that causes cells to become cancerous in the first place. To perform this medical feat, however, scientists have to overcome two major challenges.

First, researchers have not been able to pinpoint a specific gene that can stop the progression of mesothelioma in most patients. The likeliest candidates are natural tumor-suppressing genes that prevent genetic mutations or ensure mutant cells self-destruct before they grow into tumors. The p53 gene, the BAP1 gene and microRNA gene 16 have all been studied as genes that may be able to stop the progression of mesothelioma.

Second, inserting these tumor-suppressing genes requires a microscopic delivery vehicle, or vector, that can penetrate deep into a tumor. Genetically modified viruses and specially designed nanoparticles are both in development as gene therapy vectors.

Get help connecting with the nation's top mesothelioma doctors and cancer centers.

The same vectors that could carry tumor-suppressing genes could also insert artificial suicide genes into cancer cells.

If researchers can develop a vector that infects all the cells in a tumor while leaving the rest of the bodys cells alone, it would enable a special form of targeted chemotherapy called suicide gene therapy. The artificial suicide gene causes cancer cells to produce an enzyme that converts an otherwise harmless drug into a lethal toxin, so the drug kills cancer cells while leaving healthy cells unharmed.

Rather than trying to alter cellular DNA, some researchers instead focus on modifying deadly viruses to only kill cancer cells. This approach, known as virotherapy, was discovered by accident when doctors noticed many cancer patients who contract measles experience tumor regressions. Since then, scientists have been developing modified versions of the measles virus as an experimental treatment for several types of cancer, including mesothelioma.

In a 2016 trial of virotherapy for pleural mesothelioma patients, researchers were able to safely inject a special strain of the measles vaccine directly into the cancer site, potentially fighting the cancer through viral infection as well as provoking a natural immune system response against the cancer.

The most exciting recent development lies at the intersection of gene therapy and immunotherapy, another cutting-edge cancer treatment science. The first gene therapy for cancer approved by the FDA is known by the brand name Kymriah and generically referred to as CAR T-cell therapy. Kymriahs makers call it a living drug, because it is produced by extracting the patients own immune cells and reprogramming them to target cancer.

CAR T-cell therapy represents one of the first truly individualized and targeted cancer treatments, but it also has significant limitations: Kymriah is FDA-approved only for leukemia, it is extremely expensive, and it comes with the risk of severe side effects. Nevertheless, this technology has the potential to improve outcomes for mesothelioma patients in the future.

Last Modified September 25, 2018

Registered Nurse and Patient Advocate

Karen Selby joined Asbestos.com in 2009. She is a registered nurse with a background in oncology and thoracic surgery and was the director of a tissue bank before becoming a Patient Advocate at The Mesothelioma Center. Karen has assisted surgeons with thoracic surgeries such as lung resections, lung transplants, pneumonectomies, pleurectomies and wedge resections. She is also a member of the Academy of Oncology Nurse & Patient Navigators.

6 Cited Article Sources

More here:

Gene-Therapy - Experimental Mesothelioma Treatment

Vectors in gene therapy – Wikipedia

Gene therapy utilizes the delivery of DNA into cells, which can be accomplished by several methods, summarized below. The two major classes of methods are those that use recombinant viruses (sometimes called biological nanoparticles or viral vectors) and those that use naked DNA or DNA complexes (non-viral methods).

All viruses bind to their hosts and introduce their genetic material into the host cell as part of their replication cycle. This genetic material contains basic 'instructions' of how to produce more copies of these viruses, hacking the body's normal production machinery to serve the needs of the virus. The host cell will carry out these instructions and produce additional copies of the virus, leading to more and more cells becoming infected. Some types of viruses insert their genome into the host's cytoplasm, but do not actually enter the cell. Others penetrate the cell membrane disguised as protein molecules and enter the cell.

There are two main types of virus infection: lytic and lysogenic. Shortly after inserting its DNA, viruses of the lytic cycle quickly produce more viruses, burst from the cell and infect more cells. Lysogenic viruses integrate their DNA into the DNA of the host cell and may live in the body for many years before responding to a trigger. The virus reproduces as the cell does and does not inflict bodily harm until it is triggered. The trigger releases the DNA from that of the host and employs it to create new viruses.[citation needed]

The genetic material in retroviruses is in the form of RNA molecules, while the genetic material of their hosts is in the form of DNA. When a retrovirus infects a host cell, it will introduce its RNA together with some enzymes, namely reverse transcriptase and integrase, into the cell. This RNA molecule from the retrovirus must produce a DNA copy from its RNA molecule before it can be integrated into the genetic material of the host cell. The process of producing a DNA copy from an RNA molecule is termed reverse transcription. It is carried out by one of the enzymes carried in the virus, called reverse transcriptase. After this DNA copy is produced and is free in the nucleus of the host cell, it must be incorporated into the genome of the host cell. That is, it must be inserted into the large DNA molecules in the cell (the chromosomes). This process is done by another enzyme carried in the virus called integrase.[citation needed]

Now that the genetic material of the virus has been inserted, it can be said that the host cell has been modified to contain new genes. If this host cell divides later, its descendants will all contain the new genes. Sometimes the genes of the retrovirus do not express their information immediately.[citation needed]

One of the problems of gene therapy using retroviruses is that the integrase enzyme can insert the genetic material of the virus into any arbitrary position in the genome of the host; it randomly inserts the genetic material into a chromosome. If genetic material happens to be inserted in the middle of one of the original genes of the host cell, this gene will be disrupted (insertional mutagenesis). If the gene happens to be one regulating cell division, uncontrolled cell division (i.e., cancer) can occur. This problem has recently begun to be addressed by utilizing zinc finger nucleases[1] or by including certain sequences such as the beta-globin locus control region to direct the site of integration to specific chromosomal sites.

Gene therapy trials using retroviral vectors to treat X-linked severe combined immunodeficiency (X-SCID) represent the most successful application of gene therapy to date. More than twenty patients have been treated in France and Britain, with a high rate of immune system reconstitution observed. Similar trials were restricted or halted in the USA when leukemia was reported in patients treated in the French X-SCID gene therapy trial.[citation needed] To date, four children in the French trial and one in the British trial have developed leukemia as a result of insertional mutagenesis by the retroviral vector. All but one of these children responded well to conventional anti-leukemia treatment. Gene therapy trials to treat SCID due to deficiency of the Adenosine Deaminase (ADA) enzyme (one form of SCID)[2] continue with relative success in the USA, Britain, Ireland, Italy and Japan.[citation needed]

Adenoviruses are viruses that carry their genetic material in the form of double-stranded DNA. They cause respiratory, intestinal, and eye infections in humans (especially the common cold). When these viruses infect a host cell, they introduce their DNA molecule into the host. The genetic material of the adenoviruses is not incorporated (transient) into the host cell's genetic material. The DNA molecule is left free in the nucleus of the host cell, and the instructions in this extra DNA molecule are transcribed just like any other gene. The only difference is that these extra genes are not replicated when the cell is about to undergo cell division so the descendants of that cell will not have the extra gene.[citation needed]

As a result, treatment with the adenovirus will require readministration in a growing cell population although the absence of integration into the host cell's genome should prevent the type of cancer seen in the SCID trials. This vector system has been promoted for treating cancer and indeed the first gene therapy product to be licensed to treat cancer, Gendicine, is an adenovirus. Gendicine, an adenoviral p53-based gene therapy was approved by the Chinese food and drug regulators in 2003 for treatment of head and neck cancer. Advexin, a similar gene therapy approach from Introgen, was turned down by the US Food and Drug Administration (FDA) in 2008.[citation needed]

Concerns about the safety of adenovirus vectors were raised after the 1999 death of Jesse Gelsinger while participating in a gene therapy trial. Since then, work using adenovirus vectors has focused on genetically crippled versions of the virus.[citation needed]

The viral vectors described above have natural host cell populations that they infect most efficiently. Retroviruses have limited natural host cell ranges, and although adenovirus and adeno-associated virus are able to infect a relatively broader range of cells efficiently, some cell types are refractory to infection by these viruses as well. Attachment to and entry into a susceptible cell is mediated by the protein envelope on the surface of a virus. Retroviruses and adeno-associated viruses have a single protein coating their membrane, while adenoviruses are coated with both an envelope protein and fibers that extend away from the surface of the virus. The envelope proteins on each of these viruses bind to cell-surface molecules such as heparin sulfate, which localizes them upon the surface of the potential host, as well as with the specific protein receptor that either induces entry-promoting structural changes in the viral protein, or localizes the virus in endosomes wherein acidification of the lumen induces this refolding of the viral coat. In either case, entry into potential host cells requires a favorable interaction between a protein on the surface of the virus and a protein on the surface of the cell.[citation needed]

For the purposes of gene therapy, one might either want to limit or expand the range of cells susceptible to transduction by a gene therapy vector. To this end, many vectors have been developed in which the endogenous viral envelope proteins have been replaced by either envelope proteins from other viruses, or by chimeric proteins. Such chimera would consist of those parts of the viral protein necessary for incorporation into the virion as well as sequences meant to interact with specific host cell proteins. Viruses in which the envelope proteins have been replaced as described are referred to as pseudotyped viruses. For example, the most popular retroviral vector for use in gene therapy trials has been the lentivirus Simian immunodeficiency virus coated with the envelope proteins, G-protein, from Vesicular stomatitis virus. This vector is referred to as VSV G-pseudotyped lentivirus, and infects an almost universal set of cells. This tropism is characteristic of the VSV G-protein with which this vector is coated. Many attempts have been made to limit the tropism of viral vectors to one or a few host cell populations. This advance would allow for the systemic administration of a relatively small amount of vector. The potential for off-target cell modification would be limited, and many concerns from the medical community would be alleviated. Most attempts to limit tropism have used chimeric envelope proteins bearing antibody fragments. These vectors show great promise for the development of "magic bullet" gene therapies.[citation needed]

A replication-competent vector called ONYX-015 is used in replicating tumor cells. It was found that in the absence of the E1B-55Kd viral protein, adenovirus caused very rapid apoptosis of infected, p53(+) cells, and this results in dramatically reduced virus progeny and no subsequent spread. Apoptosis was mainly the result of the ability of EIA to inactivate p300. In p53(-) cells, deletion of E1B 55kd has no consequence in terms of apoptosis, and viral replication is similar to that of wild-type virus, resulting in massive killing of cells.[citation needed]

A replication-defective vector deletes some essential genes. These deleted genes are still necessary in the body so they are replaced with either a helper virus or a DNA molecule.[3]

Replication-defective vectors always contain a transfer construct. The transfer construct carries the gene to be transduced or transgene. The transfer construct also carries the sequences which are necessary for the general functioning of the viral genome: packaging sequence, repeats for replication and, when needed, priming of reverse transcription. These are denominated cis-acting elements, because they need to be on the same piece of DNA as the viral genome and the gene of interest. Trans-acting elements are viral elements, which can be encoded on a different DNA molecule. For example, the viral structural proteins can be expressed from a different genetic element than the viral genome.[3]

The herpes simplex virus is a human neurotropic virus. This is mostly examined for gene transfer in the nervous system. The wild type HSV-1 virus is able to infect neurons and evade the host immune response, but may still become reactivated and produce a lytic cycle of viral replication. Therefore, it is typical to use mutant strains of HSV-1 that are deficient in their ability to replicate. Though the latent virus is not transcriptionally apparent, it does possess neuron specific promoters that can continue to function normally.[further explanation needed] Antibodies to HSV-1 are common in humans, however complications due to herpes infection are somewhat rare.[4] Caution for rare cases of encephalitis must be taken and this provides some rationale to using HSV-2 as a viral vector as it generally has tropism for neuronal cells innervating the urogenital area of the body and could then spare the host of severe pathology in the brain.[citation needed]

Non-viral methods present certain advantages over viral methods, with simple large scale production and low host immunogenicity being just two. Previously, low levels of transfection and expression of the gene held non-viral methods at a disadvantage; however, recent advances in vector technology have yielded molecules and techniques with transfection efficiencies similar to those of viruses.[5]

This is the simplest method of non-viral transfection. Clinical trials carried out of intramuscular injection of a naked DNA plasmid have occurred with some success; however, the expression has been very low in comparison to other methods of transfection. In addition to trials with plasmids, there have been trials with naked PCR product, which have had similar or greater success. Cellular uptake of naked DNA is generally inefficient. Research efforts focusing on improving the efficiency of naked DNA uptake have yielded several novel methods, such as electroporation, sonoporation, and the use of a "gene gun", which shoots DNA coated gold particles into the cell using high pressure gas.[6]

Electroporation is a method that uses short pulses of high voltage to carry DNA across the cell membrane. This shock is thought to cause temporary formation of pores in the cell membrane, allowing DNA molecules to pass through. Electroporation is generally efficient and works across a broad range of cell types. However, a high rate of cell death following electroporation has limited its use, including clinical applications.

More recently a newer method of electroporation, termed electron-avalanche transfection, has been used in gene therapy experiments. By using a high-voltage plasma discharge, DNA was efficiently delivered following very short (microsecond) pulses. Compared to electroporation, the technique resulted in greatly increased efficiency and less cellular damage.

The use of particle bombardment, or the gene gun, is another physical method of DNA transfection. In this technique, DNA is coated onto gold particles and loaded into a device which generates a force to achieve penetration of the DNA into the cells, leaving the gold behind on a "stopping" disk.

Sonoporation uses ultrasonic frequencies to deliver DNA into cells. The process of acoustic cavitation is thought to disrupt the cell membrane and allow DNA to move into cells.

In a method termed magnetofection, DNA is complexed to magnetic particles, and a magnet is placed underneath the tissue culture dish to bring DNA complexes into contact with a cell monolayer.

Hydrodynamic delivery involves rapid injection of a high volume of a solution into vasculature (such as into the inferior vena cava, bile duct, or tail vein). The solution contains molecules that are to be inserted into cells, such as DNA plasmids or siRNA, and transfer of these molecules into cells is assisted by the elevated hydrostatic pressure caused by the high volume of injected solution.[7][8][9]

The use of synthetic oligonucleotides in gene therapy is to deactivate the genes involved in the disease process. There are several methods by which this is achieved. One strategy uses antisense specific to the target gene to disrupt the transcription of the faulty gene. Another uses small molecules of RNA called siRNA to signal the cell to cleave specific unique sequences in the mRNA transcript of the faulty gene, disrupting translation of the faulty mRNA, and therefore expression of the gene. A further strategy uses double stranded oligodeoxynucleotides as a decoy for the transcription factors that are required to activate the transcription of the target gene. The transcription factors bind to the decoys instead of the promoter of the faulty gene, which reduces the transcription of the target gene, lowering expression. Additionally, single stranded DNA oligonucleotides have been used to direct a single base change within a mutant gene. The oligonucleotide is designed to anneal with complementarity to the target gene with the exception of a central base, the target base, which serves as the template base for repair. This technique is referred to as oligonucleotide mediated gene repair, targeted gene repair, or targeted nucleotide alteration.

To improve the delivery of the new DNA into the cell, the DNA must be protected from damage and positively charged. Initially, anionic and neutral lipids were used for the construction of lipoplexes for synthetic vectors. However, in spite of the facts that there is little toxicity associated with them, that they are compatible with body fluids and that there was a possibility of adapting them to be tissue specific; they are complicated and time consuming to produce so attention was turned to the cationic versions.

Cationic lipids, due to their positive charge, were first used to condense negatively charged DNA molecules so as to facilitate the encapsulation of DNA into liposomes. Later it was found that the use of cationic lipids significantly enhanced the stability of lipoplexes. Also as a result of their charge, cationic liposomes interact with the cell membrane, endocytosis was widely believed as the major route by which cells uptake lipoplexes. Endosomes are formed as the results of endocytosis, however, if genes can not be released into cytoplasm by breaking the membrane of endosome, they will be sent to lysosomes where all DNA will be destroyed before they could achieve their functions. It was also found that although cationic lipids themselves could condense and encapsulate DNA into liposomes, the transfection efficiency is very low due to the lack of ability in terms of endosomal escaping. However, when helper lipids (usually electroneutral lipids, such as DOPE) were added to form lipoplexes, much higher transfection efficiency was observed. Later on, it was figured out that certain lipids have the ability to destabilize endosomal membranes so as to facilitate the escape of DNA from endosome, therefore those lipids are called fusogenic lipids. Although cationic liposomes have been widely used as an alternative for gene delivery vectors, a dose dependent toxicity of cationic lipids were also observed which could limit their therapeutic usages.

The most common use of lipoplexes has been in gene transfer into cancer cells, where the supplied genes have activated tumor suppressor control genes in the cell and decrease the activity of oncogenes. Recent studies have shown lipoplexes to be useful in transfecting respiratory epithelial cells.

Polymersomes are synthetic versions of liposomes (vesicles with a lipid bilayer), made of amphiphilic block copolymers. They can encapsulate either hydrophilic or hydrophobic contents and can be used to deliver cargo such as DNA, proteins, or drugs to cells. Advantages of polymersomes over liposomes include greater stability, mechanical strength, blood circulation time, and storage capacity.[10][11][12]

Complexes of polymers with DNA are called polyplexes. Most polyplexes consist of cationic polymers and their fabrication is based on self-assembly by ionic interactions. One important difference between the methods of action of polyplexes and lipoplexes is that polyplexes cannot directly release their DNA load into the cytoplasm. As a result, co-transfection with endosome-lytic agents such as inactivated adenovirus was required to facilitate nanoparticle escape from the endocytic vesicle made during particle uptake. However, a better understanding of the mechanisms by which DNA can escape from endolysosomal pathway, i.e. proton sponge effect,[13] has triggered new polymer synthesis strategies such as incorporation of protonable residues in polymer backbone and has revitalized research on polycation-based systems.[14]

Due to their low toxicity, high loading capacity, and ease of fabrication, polycationic nanocarriers demonstrate great promise compared to their rivals such as viral vectors which show high immunogenicity and potential carcinogenicity, and lipid-based vectors which cause dose dependence toxicity. Polyethyleneimine[15] and chitosan are among the polymeric carriers that have been extensively studies for development of gene delivery therapeutics. Other polycationic carriers such as poly(beta-amino esters)[16] and polyphosphoramidate[17] are being added to the library of potential gene carriers. In addition to the variety of polymers and copolymers, the ease of controlling the size, shape, surface chemistry of these polymeric nano-carriers gives them an edge in targeting capability and taking advantage of enhanced permeability and retention effect.[18]

A dendrimer is a highly branched macromolecule with a spherical shape. The surface of the particle may be functionalized in many ways and many of the properties of the resulting construct are determined by its surface.

In particular it is possible to construct a cationic dendrimer, i.e. one with a positive surface charge. When in the presence of genetic material such as DNA or RNA, charge complimentarity leads to a temporary association of the nucleic acid with the cationic dendrimer. On reaching its destination the dendrimer-nucleic acid complex is then taken into the cell via endocytosis.

In recent years the benchmark for transfection agents has been cationic lipids. Limitations of these competing reagents have been reported to include: the lack of ability to transfect some cell types, the lack of robust active targeting capabilities, incompatibility with animal models, and toxicity. Dendrimers offer robust covalent construction and extreme control over molecule structure, and therefore size. Together these give compelling advantages compared to existing approaches.

Producing dendrimers has historically been a slow and expensive process consisting of numerous slow reactions, an obstacle that severely curtailed their commercial development. The Michigan-based company Dendritic Nanotechnologies discovered a method to produce dendrimers using kinetically driven chemistry, a process that not only reduced cost by a magnitude of three, but also cut reaction time from over a month to several days. These new "Priostar" dendrimers can be specifically constructed to carry a DNA or RNA payload that transfects cells at a high efficiency with little or no toxicity.[citation needed]

Inorganic nanoparticles, such as gold, silica, iron oxide (ex. magnetofection) and calcium phosphates have been shown to be capable of gene delivery.[19] Some of the benefits of inorganic vectors is in their storage stability, low manufacturing cost and often time, low immunogenicity, and resistance to microbial attack. Nanosized materials less than 100nm have been shown to efficiently trap the DNA or RNA and allows its escape from the endosome without degradation. Inorganics have also been shown to exhibit improved in vitro transfection for attached cell lines due to their increased density and preferential location on the base of the culture dish. Quantum dots have also been used successfully and permits the coupling of gene therapy with a stable fluorescence marker. Engineered organic nanoparticles are also under development, which could be used for co-delivery of genes and therapeutic agents.[20]

Cell-penetrating peptides (CPPs), also known as peptide transduction domains (PTDs), are short peptides (< 40 amino acids) that efficiently pass through cell membranes while being covalently or non-covalently bound to various molecules, thus facilitating these molecules entry into cells. Cell entry occurs primarily by endocytosis but other entry mechanisms also exist. Examples of cargo molecules of CPPs include nucleic acids, liposomes, and drugs of low molecular weight.[21][22]

CPP cargo can be directed into specific cell organelles by incorporating localization sequences into CPP sequences. For example, nuclear localization sequences are commonly used to guide CPP cargo into the nucleus.[23] For guidance into mitochondria, a mitochondrial targeting sequence can be used; this method is used in protofection (a technique that allows for foreign mitochondrial DNA to be inserted into cells' mitochondria).[24][25]

Due to every method of gene transfer having shortcomings, there have been some hybrid methods developed that combine two or more techniques. Virosomes are one example; they combine liposomes with an inactivated HIV or influenza virus. This has been shown to have more efficient gene transfer in respiratory epithelial cells than either viral or liposomal methods alone. Other methods involve mixing other viral vectors with cationic lipids or hybridising viruses.[26]

Follow this link:

Vectors in gene therapy - Wikipedia

5 Kinds of Complementary and Alternative Medicine (CAM)

Complementary and alternative medicine comes in a broad range of forms. Here's a look at five widely practiced types of complementary and alternative medicine:

According to the National Center for Complementary and Integrative Health (NCCIH), the most commonly used complementary medicine approaches in the U.S. fall into one of two subgroups: natural products or mind-body practices.

In the 2012 National Health Interview Survey (or NHIS, a report conducted by the Centers for Disease Control and Prevention's National Center for Health Statistics), researchers determined that 17.7 percent of American adults had used a dietary supplement other than vitamins and minerals in the past year. The most commonly used natural product was fish oil, an omega-3-rich substance said to protect against conditions such as heart disease.

The second category of most commonly practiced complementary medicine approaches, according to the NCCIH, mind-body therapies typically involve using specific techniques to boost the mind's capacity to influence bodily function and enhance health.

Hypnotherapy is a popular type of mind-body therapy. Also known as hypnosis, it's been found to promote weight loss, alleviate back pain, and aid in smoking cessation in some scientific studies.

A self-directed practice long used to promote calm, meditation is a mind-body therapy that shows promise as an approach to achieving healthier blood pressure and sounder sleep. There's also some evidence that meditation may benefit people struggling with chronic pain.

Although yoga is often practiced as a form of exercise and a means of reducing stress, it's also used as a mind-body therapy. Indeed, some research indicates that yoga may help manage conditions like anxiety, insomnia, migraines, and depression.

The NCCIH notes that yoga's popularity has significantly increased in recent years, with almost twice as many U.S. adults practicing yoga in 2012 as in 2002.

Many proponents of complementary and alternative medicine use therapies and healing practices from alternative medical systems, such as homeopathy and naturopathic medicine.

Alternative medical systems also include traditional medical systems from other countries, such as Ayurveda (a form of alternative medicine that originated in India) and traditional Chinese medicine (TCM). Within TCM are a number of therapies frequently used in the U.S. today, including acupuncture, acupressure, and herbal medicine.

This type of complementary and alternative medicine is based on manipulation and/or movement of one or more parts of the body.

In some cases, manipulative and body-based methods involve participating in classes or individual sessions with the aim of changing your movement habits. For example, the Alexander Techniqueinvolves relearning basic movements (such as standing and sitting) in order to reduce muscle tension, while the Feldenkrais Method involves creating new patterns of movement in order to improve physical function and overall wellbeing.

Other types of manipulative and body-based methods used in complementary and alternative medicine focus on applying specific treatments to address health issues. These methods include reflexology, osteopathy, and rolfing.

Another type of complementary and alternative medicine, energy therapies are generally based on the idea that energy fields surround and penetrate the human body. Practitioners of energy therapies often aim to manipulate biofields by applying pressure and/or placing the hands in or through these energy fields.

While the existence of such energy fields has not been scientifically proven, there's some evidence that certain energy therapies may have beneficial effects.

For instance, preliminary research has shown that practicing qigongmay help control chronic pain and lower blood pressure while Therapeutic Touch may help soothe osteoarthritis pain. In addition, there's some evidence that reiki may help lessen pain, promote healthy sleep, and reduce anxiety.

Read the original post:

5 Kinds of Complementary and Alternative Medicine (CAM)

Satoshi Nakamoto Revealed Says UK Nonprofit Stylometry …

Self-described informative and interactive crypto website, Zy Crypto, a nonprofit based in England, believes it has struck ecosystem gold by discovering Satoshi Nakamotos real identity. Its the second attempt by the outfit, and both times theyve relied upon stylometry before concluding that Bitcoin Cash developer Gavin Andresen is Satoshi hiding in plain sight. This go-round analysis involves not only statistical analysis of prose, but also Maciej Eders bootstrapping method in an attempt to eliminate natural bias in such conclusions.

Also read: Apple Sides with Russian Govt, Restricts Telegram, Claims Pavel Durov

Two upfront admittances, if readers indulge. The first is, I am a Troy Watson fan. I enjoy his work, and count myself as someone who approves of his earnest dive into such subjects. Second, I have probably read more about the present pseudonym under examination than is healthy, and not just because I make my living in the space. Flatly, I am obsessed. No clickbait here, or not intentionally. No hype. This is a fun pursuit, and one worth some effort as it involves cryptocurrencys origin story.

Zy Crypto is a curious little outfit based in a lesser-known part of the United Kingdom. Theyve the site proper, a news aggregation service, and what appear to be variations on the public relations themes of initial coin offerings and blockchains. To publish one, let alone two articles asserting both times how Bitcoin Cash developer Gavin Andresen is Satoshi, for once and for all, speaks volumes about either the confidence Zy has in its writer or the fact theyre sporting for clicks.

Consider this sentence, hitting readers right between the eyes: We identified Bitcoin Cash developer Gavin Andresen as being the real Satoshi Nakamoto, Mr. Watson boldly asserts before an immediate pivot towards technique. The primary methodology used in both examinations is whats known as stylometry. Its the study of prose put up against other writers as a way of determining patterns and is an actual predictive of authorship when done well.

Stylometry has picked up in recent years as an investigative tool when faced with the spectre of Satoshi Nakamoto. The pseudo anonymous creator of Bitcoin holds more than five percent of bitcoin in circulation, making him the first crypto billionaire. Should Mr. Nakamoto decide for shits and giggles to dump a significant amount of coin onto the market, not only would the price drop by virtue of economic law, confidence would probably crash as well, bringing down a giant chunk of whatever value bitcoin has. Its a big goddamn deal who Satoshi is.

The technology to out a writer wishing to remain in has proven its worth. In the mid 1960s, Frederick Mosteller used stylometry to establish authorship of the hotly contested Federalist Papers, determining James Madison as their probable main author (instead of Alexander Hamilton). It took him almost half a decade, whereas today software exists to run such analysis pretty fast. More famously, and recently, no less an author than zillion-selling Harry Potter creator JK Rowling was found to be the actual author of The Cuckoos Calling. A few years ago she wished to have her writing evaluated on its own merits, and so Ms. Rowling took a pen name. Stylometry outed her.

And Zy Crypto isnt the first to attempt applying the statistical method to Satoshis true identity. As bitcoins price began to skyrocket, so did interest in who its creator mightve been. During Craig Wrights supremely odd public display, outed by supposed hackers, claiming to be Satoshi and then suggesting it was a hoax, a couple of once well-regarded tech journals believed Mr. Wright to be Satoshi. International Business Times employed the very firm used to blow Ms. Rowlings cover, Juola & Associates. They soon determined what most in the know suspected: Mr. Wright wasnt bitcoins father (hed respond that he and partner David Kleiman collaborated on the project, but even that has been posthumously tainted). He managed to fool or convince or onboard original Bitcoin dev Gavin Andresen, who went so far as to record video testimony (Vitalik Buterin, Ethereum genius, weighed in on the noise of the matter, and later just outright spat fraud in Mr. Wrights direction).

Late 2017, price fever pitch reached maximum overdrive, and Michael Chon took his own swing at discovery. The Georgetown University and Booz Allen Hamilton alum concluded Satoshi was a group of devs, with some authoring the whitepaper while others engaged in email exchanges. He narrowed it down to four: Nick Szabo, Ian Grigg, Wei Dai, and Timothy C. May. Gavin Andresen wasnt considered, a subject to which we return.

Mr. Watson details how using Eders bootstrapped stylometry methodthis finding supports our previous article on the topic that also identified Gavin as Satoshi using Principal Component Analysis and Burrows delta. Knowing full well the history Ive outlined above, he concludes, A big part of this failure can be attributed to the lack of convergence validity in the stylometry field. And a pitfall within the field itself is how stylometrics often cherry pick results due to their algorithms producing vastly different results when slightly tweaked, he acknowledged. This led to suggesting Wei Dai as Satoshi, at least for a time.

This time, Mr. Watsons confidence in Mr. Andresen as Satoshi extends from Maciej Eder, who created a bootstrapping method specifically designed to overcome the problem of cherry picking elements like Most Frequent Words (MFW). The approach uses Burrows delta to find a difference between two texts, but also uses random sampling of MFW ranges so as to output more robust results. Burrows delta is basically a manhattan distance of z-scores which is sourced from a list of top words used in an entire corpus.

The rest of the article reads similarly, and the interested would do well with frequent searches of Wikipedia. Nevertheless, hes found that the first nearest neighbour was Satoshis email texts followed by 3 of Gavin Andresens Github documents and then followed by Satoshis forum texts. These findings are quite reasonable because not only do they validate the links between the Satoshi whitepaper-emails-forums but they also cluster Gavin as the likely author. Its also of interest that Gavins style was so much like Satoshis whitepaper that he beat Satoshi himself with the forum texts!

Still more discussion of limitations and technical methodology follows, and those without a statistical or mathematical background are cautioned. Its somewhat like reading French if you dont speak French. Yeah, theres the standard Latin alphabet and all, but thats about as far as most will get. Again, Wikipedia is a friend.I dont buy it in the end, and have instead relied upon resident ecosystem muckraker, Crypto Cornelius, as my prime response. I have identified Myself, he typed in the patois of most these studies, an amateur crypto enthusiast as being the real Satoshi Nakamoto using Yeders bootstrapped Coronary Angiogram stylometry method. This finding supports a previous thought when I woke up one night and thought Could I be Nakamoto? Sides splitting, tears dropping on the laptop as I type to you Dear Reader, he continues, Nano Stylometry was invented by Elon Musk and is a set of methods that aim to identify an unknown author by statistically deciphering their style using statistics, hard to understand graphics and random information. For geeks like me, good old Cornelius is necessary to bring us back to reality. Happy reading.

Is Gavin the real Satoshi? Let us know in the comments.

Images via the Pixabay, Twitter, giuatt07.

Verify and track bitcoin cash transactions on ourBCH Block Explorer, the best of its kind anywhere in the world. Also, keep up with your holdings, BCH and other coins, on our market charts atSatoshis Pulse, another original and free service from Bitcoin.com.

Continue reading here:

Satoshi Nakamoto Revealed Says UK Nonprofit Stylometry ...

Oceania (The Smashing Pumpkins album) – Wikipedia

Oceania is the eighth studio album by American alternative rock band The Smashing Pumpkins, released on June 19, 2012 through EMI, Reprise Records and Martha's Music. Produced by Billy Corgan and Bjorn Thorsrud, the album is part of the band's abandoned 44-song project album, Teargarden by Kaleidyscope.[5]As of September 2012, Oceania has sold over 102,000 copies in the US.[6]

A live performance of the album, Oceania: Live in NYC, was released on September 24, 2013.[7]

Contents

On April 26, 2011, in a video on the band's Facebook fan page, frontman Billy Corgan announced plans to release Oceania as "an album within an album,"[8] relating to Teargarden by Kaleidyscope which involved releasing songs one by one, for free on the Internet from late 2009, and then releasing them in EPs after claiming that albums are a dead medium. While Oceania may appear to contradict that, Corgan explains:

"I still stand by my view that I don't think albums are particularly relevant at this time. That may change. But as far as making music...from a writing point of view, it's really going to focus me to put a group of songs together that are supposed to go together."[9]

Corgan later admitted that they switched back to the album format because he "...reached a point where I saw that the one-song-at-a-time idea had maxed itself out...I just saw we weren't getting the penetration in to everybody that I would have hoped."[10]

The band finished mixing the album on September 18, 2011.[11]

Oceania was the first full-length album recorded with guitarist Jeff Schroeder, and the only album recorded with drummer Mike Byrne and bassist Nicole Fiorentino. The band was supplemented in-studio by an unnamed session keyboardist.[12] Fiorentino had this to say about her role in recording Oceania:

"I think because we are all working together on this record it is naturally going to have a different vibe than any of the other records on which Billy played most of the instruments himself. I think we delved into new territory for sure, but what I love about this record is that it has that familiar old-school Pumpkins feel to it, with a modern twist. The cool thing is he was able to capture the energy of the old material without ripping it off. Billy's definitely found his way back to whatever he was tapping into when writing Gish and Siamese Dream."[13]

Guitarist Jeff Schroeder also hinted that the album may be less heavy than past albums, stating "In this day and age, with what's going on politically and socially, it just feels right to play something that's a little more spacey and dreamy. We want music to move people on an emotional level."[14]

In November 2011, the album's release date was pushed back to spring 2012 and announced via Twitter.[15]

Corgan has said that Oceania is the Pumpkins' "best effort since Mellon Collie". Comparing it to his previous works, he said, "it is the first time where you actually hear me escape the old band. I'm not reacting against it or for it or in the shadow of it." [16]

In describing Oceania's theme, Billy Corgan said the album is partly about "people struggling to find a social identity in today's fast-paced, technology-rich culture", adding "I think alienation seems to be the key theme alienation in love and alienation in culture," he says.[17]

Regarding the album's lyrical content, Corgan noted "If you listen to the lyrics, it was written around some serious relationship strife. When somebody breaks your heart, you can choose to accept, embrace, and forgive them, as opposed to condemn them. I got a few albums out of [sic] condemn! Now I'm working on compassion as a device."[18]

The album was tentatively scheduled to be released on September 1, 2011,[19] but the release date was pushed to June 19, 2012.[20] On March 27, 2012, EMI/Caroline Distribution announced that it has entered into an exclusive agreement with Martha's Music to release the album on June 19, 2012.[21] In late May 2012, the band announced that they were holding an event called "Imagine Oceania", requesting fans to take and submit their own photos for the album.[22] On June 12, the album was made available to stream in full via iTunes.[23] The album also became available for full streaming on Spotify, Soundcloud, Spinner, and Ustream. Corgan appeared on The Howard Stern Show on June 19, performing an acoustic version of "Tonight, Tonight". Howard Stern interviewed Corgan for more than an hour and premiered "Violet Rays" from the album.[24] On June 21, 2012, "The Celestials" was released as the album's first single.[25] They performed the song on The Tonight Show with Jay Leno on August 23, 2012.[26] "Panopticon" was released as the second single on September 15, 2012.[27]In 2014, the song "My Love is Winter" was featured on the soundtrack for the video game Watch Dogs.[28]

The album cover features the North Shore Sanitary District Tower.

According to Billboard, the album in its first week of release sold 54,000 copies in the US, debuted at number four on the Billboard 200 chart and at number one on the Independent Albums chart[41]making it the band's seventh top 10 album to date.[42] The album has received generally positive reviews, with many reviewers finding Oceania to be a return to form for Corgan. On Metacritic, which assigns a normalized rating out of 100 to reviews from mainstream critics, the album has received thus far an average score of 72, indicating "generally favorable reviews".[29] RedEye gave the album three stars out of four, saying "Oceania, the first full-length Pumpkins album since 2007's Zeitgeist, is the best thing Corgan and Co. have produced in quite some time. Longtime fans will hear hints of the grungy, vicious band of the Gish era and also the mellow, almost pop Adore era. It's a mix that works."[43] Antiquiet gave album four out of five stars and called it "best Corgan work in a decade".[44] Gigwise gave the album four stars out of five and praised its production and themes.[45] Toronto Sun gave the album four stars out of five, saying "With Billy Corgan, bigger is better. And his latest projectthe ongoing 44-song Teargarden by Kaleidyscopeis his most ambitious since 2000's Machina. In keeping, this 'album-within-an-album' bears all the classic Pumpkins hallmarks: Searing guitars and busy drums, epic songs and complex arrangements, wistful romanticism and bombastic grandeur. His best work in years."[46]

PopMatters gave the album seven out of 10 stars, describing the album as "...a spinoff that doesn't hold the brilliance of an original, but is charismatic in its own right. A more grown-up manifestation of the adolescent self-obsessed gloomy beginnings."[47] BBC gave the album a positive review, saying "On Oceania Smashing Pumpkins sound energised and alive." About.com gave the album four stars out of five, saying "Corgan has claimed that friends who had heard Oceania had claimed it was his best since Mellon Collie and the Infinite Sadness. Time will tell, but for now it's clear that Oceania is the first Smashing Pumpkins record since then to fully stimulate the senses and stir the heart." Allmusic gave the album four out of five stars, saying "On Oceania there are some of the most memorable and rousing songs Corgan has delivered since 1993's Siamese Dream". ARTISTdirect gave the album a five out of five stars, saying "Oceania is the year's best rock record and a milestone for the genre. Hopefully, it incites and inspires a new generation. The Pumpkins are no strangers to that concept..."[48] Ology gave the album a B+, stating it is "...simply a really good new album, one that deserves to be referenced and included in the company of the classic Smashing Pumpkins albums it delightfully demonstrates little interest in resembling."[35] The Chicago Sun-Times gave the album four out of four stars, saying "this album within an album revives Corgan's gutter-epic vision with a clarity and ferocity not seen since 1995's Mellon Collie and the Infinite Sadness."[49] Daily Express gave the album four out of fivestars, saying "Oceania is Corgan on especially potent form". Sputnikmusic gave the album four out of fivestars, saying "SP have forged ahead to create a record that could well be the catalyst of a stellar second era for one of rock's more interesting groups".[39]

Kerrang gave the album four stars.[50] and NME gave the album six out of 10 stars and criticised the album because it doesn't feature the original band members.[51] In a brief review, Rolling Stone gave the album three out of five stars and called it "bong prog" and said that Oceania "sounds like Yes hanging in a German disco circa 1977",[52] Stereogum gave album a positive review, calling it a return to form.[53]USA Today gave the album 3.5 out of four stars, praising the production and song writing.[54] The A.V. Club gave the album a B and called it "a solid start to a new Smashing Pumpkins era".[55] Pitchfork Media rated the album 6.3 out of 10, purporting that on Oceania, Corgan plays with a "hired-via-contest crew of strangers" and that it is "difficult not to notice he's repeating himself," comparing several new songs to earlier Smashing Pumpkins hits.[36]Daily Nebraskan gave the album A and called it "one of this years best rock records".[56] Consequence of Sound gave the album four out of five stars and called it "best Corgan work in a long time".[57] CraveOnline gave Oceania an 8 out of 10 review, stating that "If Oceania is a testament of what's to come, I may need to pull my old Smashing Pumpkin t-shirt out of the closet."[58] SPIN gave a rating of 7 out of 10, declaring that it is "easily Corgan's best work since his rat-in-a-cage heyday."[59] The Seattle Post-Intelligencer scored the album with 4.5 out of five stars, stating it "is full of winners."[60] The album was listed at #48 on Rolling Stone's list of the top 50 albums of 2012, saying "The most recent dispatch from whatever far-off planet Billy Corgan currently resides on is the finest slab of cosmic prog he's thrown down since the Pumpkins' early-Nineties heyday."[61]

All tracks written by Billy Corgan.

Credits adapted from Oceania album liner notes[62] and Allmusic.[63]

Link:

Oceania (The Smashing Pumpkins album) - Wikipedia

The Ron Paul Institute for Peace and Prosperity : NAFTA 2.0 …

Last week the United States, Mexico, and Canada agreed to replace the North American Free Trade Agreement (NAFTA) with a new United States-Mexico-Canada Agreement (USMCA). Sadly, instead of replacing NAFTAs managed trade with true free trade, the new USMCA expands governments control over trade.

For example, under the USMCAs rules of origin, at least 75 percent of a cars parts must be from the US, Canada, or Mexico in order to avoid tariffs. This is protectionism designed to raise prices of cars using materials from outside North America.

The USMCA also requires that 40 to 45 percent of an automobiles content be made by workers earning at least 16 dollars per hour. Like all government-set wages, this requirement will increase prices and decrease employment.

The USMCA also requires Mexico to pass legislation recognizing the right of collective bargaining. In other words, this so-called free trade agreement forces Mexico to import US-style compulsory unionism. If the Mexican legislature does not comply, the US and Canada will impose tariffs on Mexican goods.

The USMCA also requires the three countries to abide by the International Labour Organization (ILO) standards for worker rights. So, if, for example, the bureaucrats at the ILO declared that Right to Work laws violate international labor standards because they weaken collective bargaining and give Right to Work states an unfair advantage over compulsory unionism states and countries, the federal government may have to nullify all state Right to Work laws.

The USMCA also obligates the three countries to work together to improve air quality. This sounds harmless but could be used as a backdoor way to impose costly new regulations and taxes, such as a cap-and-trade scheme, on America.

This agreement also forbids the use of currency devaluation as a means of attempting to gain a competitive advantage in international trade. Enforcement of this provision will be difficult if not impossible, as no central bank will ever admit it is devaluing currency to obtain a competitive advantage in international trade. Of course, given that the very act of creating money lowers its value, the only way to stop central banks from devaluing currency is to put them out of business. Sadly, I dont think the drafters of the USMCA seek to restore free-market money.

The currency provision will likely be used to justify coordination of monetary policy between the Federal Reserve and the Mexican and Canadian central banks. This will lead to region-wide inflation and a global currency war as the US pressures Mexico and Canada to help the Fed counter other countries alleged currency manipulation and challenges to the dollars reserve currency status.

A true free trade deal would simply reduce or eliminate tariffs and other trade barriers. It would not dictate wages and labor standards, or require inter-governmental cooperation on environmental standards and monetary policy. A true free trade deal also would not, as the USMCA does, list acceptable names for types of cheeses.

Those of us who support real free trade must not let supporters of the USMCA get away with claiming the USMCA has anything to do with free trade. We must also fight the forces of protectionism that are threatening to start a destructive trade war. Also, we must work to stop the government from trying to control our economic activities through regulations, taxes, and (most importantly) control of the currency through central banking and legal tender laws.

Read more from the original source:

The Ron Paul Institute for Peace and Prosperity : NAFTA 2.0 ...

What is Cryptocurrency: Everything You Need To Know …

[Updated September 13, 2018]

What is cryptocurrency: 21st-century unicorn or the money of the future?

This introduction explains the most important thing about cryptocurrencies. After youve read it, youll know more about it than most other humans.

Today cryptocurrencies (Buy Crypto) have become a global phenomenon known to most people. While still somehow geeky and not understood by most people, banks, governments and many companies are aware of its importance.

In 2016, youll have a hard time finding a major bank, a big accounting firm, a prominent software company or a government that did not research cryptocurrencies, publish a paper about it or start a so-called blockchain-project. (Take our blockchain courses to learn more about the blockchain)

Virtual currencies, perhaps most notably Bitcoin, have captured the imagination of some, struck fear among others, and confused the heck out of the rest of us. Thomas Carper, US-Senator

But beyond the noise and the press releases the overwhelming majority of people even bankers, consultants, scientists, and developers have a very limited knowledge about cryptocurrencies. They often fail to even understand the basic concepts.

So lets walk through the whole story. What are cryptocurrencies?

Few people know, but cryptocurrencies emerged as a side product of another invention. Satoshi Nakamoto, the unknown inventor of Bitcoin, the first and still most important cryptocurrency, never intended to invent a currency.

In his announcement of Bitcoin in late 2008, Satoshi said he developed A Peer-to-Peer Electronic Cash System.

His goal was to invent something; many people failed to create before digital cash.

The single most important part of Satoshis invention was that he found a way to build a decentralized digital cash system. In the nineties, there have been many attempts to create digital money, but they all failed.

After seeing all the centralized attempts fail, Satoshi tried to build a digital cash system without a central entity. Like a Peer-to-Peer network for file sharing.

This decision became the birth of cryptocurrency. They are the missing piece Satoshi found to realize digital cash. The reason why is a bit technical and complex, but if you get it, youll know more about cryptocurrencies than most people do. So, lets try to make it as easy as possible:

To realize digital cash you need a payment network with accounts, balances, and transaction. Thats easy to understand. One major problem every payment network has to solve is to prevent the so-called double spending: to prevent that one entity spends the same amount twice. Usually, this is done by a central server who keeps record about the balances.

In a decentralized network, you dont have this server. So you need every single entity of the network to do this job. Every peer in the network needs to have a list with all transactions to check if future transactions are valid or an attempt to double spend.

But how can these entities keep a consensus about this records?

If the peers of the network disagree about only one single, minor balance, everything is broken. They need an absolute consensus. Usually, you take, again, a central authority to declare the correct state of balances. But how can you achieve consensus without a central authority?

Nobody did know until Satoshi emerged out of nowhere. In fact, nobody believed it was even possible.

Satoshi proved it was. His major innovation was to achieve consensus without a central authority. Cryptocurrencies are a part of this solution the part that made the solution thrilling, fascinating and helped it to roll over the world.

If you take away all the noise around cryptocurrencies and reduce it to a simple definition, you find it to be just limited entries in a database no one can change without fulfilling specific conditions. This may seem ordinary, but, believe it or not: this is exactly how you can define a currency.

Take the money on your bank account: What is it more than entries in a database that can only be changed under specific conditions? You can even take physical coins and notes: What are they else than limited entries in a public physical database that can only be changed if you match the condition than you physically own the coins and notes? Money is all about a verified entry in some kind of database of accounts, balances, and transactions.

How miners create coins and confirm transactions

Lets have a look at the mechanism ruling the databases of cryptocurrencies. A cryptocurrency like Bitcoin consists of a network of peers. Every peer has a record of the complete history of all transactions and thus of the balance of every account.

A transaction is a file that says, Bob gives X Bitcoin to Alice and is signed by Bobs private key. Its basic public key cryptography, nothing special at all. After signed, a transaction is broadcasted in the network, sent from one peer to every other peer. This is basic p2p-technology. Nothing special at all, again.

The transaction is known almost immediately by the whole network. But only after a specific amount of time it gets confirmed.

Confirmation is a critical concept in cryptocurrencies. You could say that cryptocurrencies are all about confirmation.

As long as a transaction is unconfirmed, it is pending and can be forged. When a transaction is confirmed, it is set in stone. It is no longer forgeable, it cant be reversed, it is part of an immutable record of historical transactions: of the so-called blockchain.

Only miners can confirm transactions. This is their job in a cryptocurrency-network. They take transactions, stamp them as legit and spread them in the network. After a transaction is confirmed by a miner, every node has to add it to its database. It has become part of the blockchain.

For this job, the miners get rewarded with a token of the cryptocurrency, for example with Bitcoins. Since the miners activity is the single most important part of cryptocurrency-system we should stay for a moment and take a deeper look on it.

Principally everybody can be a miner. Since a decentralized network has no authority to delegate this task, a cryptocurrency needs some kind of mechanism to prevent one ruling party from abusing it. Imagine someone creates thousands of peers and spreads forged transactions. The system would break immediately.

So, Satoshi set the rule that the miners need to invest some work of their computers to qualify for this task. In fact, they have to find a hash a product of a cryptographic function that connects the new block with its predecessor. This is called the Proof-of-Work. In Bitcoin, it is based on the SHA 256 Hash algorithm.

You dont need to understand details about SHA 256. Its only important you know that it can be the basis of a cryptologic puzzle the miners compete to solve. After finding a solution, a miner can build a block and add it to the blockchain. As an incentive, he has the right to add a so-called coinbase transaction that gives him a specific number of Bitcoins. This is the only way to create valid Bitcoins.

Bitcoins can only be created ifminers solve a cryptographic puzzle. Since the difficulty of this puzzle increases the amount of computer power the whole miners invest, there is only a specific amount of cryptocurrency token that can be created in a given amount of time. This is part of the consensus no peer in the network can break.

If you really think about it, Bitcoin, as a decentralized network of peers which keep a consensus about accounts and balances, is more a currency than the numbers you see in your bank account. What are these numbers more than entries in a database a database which can be changed by people you dont see and by rules you dont know?

It is that narrative of human development under which we now have other fights to fight, and I would say in the realm of Bitcoin it is mainly the separation of money and state.

Erik Voorhees,cryptocurrency entrepreneur

Basically, cryptocurrencies are entries about token in decentralized consensus-databases. They are called CRYPTOcurrencies because the consensus-keeping process is secured by strong cryptography. Cryptocurrencies are built on cryptography. They are not secured by people or by trust, but by math. It is more probable that an asteroid falls on your house than that a bitcoin address is compromised.

Describing the properties of cryptocurrencies we need to separate between transactional and monetary properties. While most cryptocurrencies share a common set of properties, they are not carved in stone.

1.) Irreversible: After confirmation, a transaction cant be reversed. By nobody. And nobody means nobody. Not you, not your bank, not the president of the United States, not Satoshi, not your miner. Nobody. If you send money, you send it. Period. No one can help you, if you sent your funds to a scammer or if a hacker stole them from your computer. There is no safety net.

2.) Pseudonymous: Neither transactions nor accounts are connected to real-world identities. You receive Bitcoins on so-called addresses, which are randomly seeming chains of around 30 characters. While it is usually possible to analyze the transaction flow, it is not necessarily possible to connect the real world identity of users with those addresses.

3.) Fast and global: Transaction are propagated nearly instantly in the network and are confirmed in a couple of minutes. Since they happen in a global network of computers they are completely indifferent of your physical location. It doesnt matter if I send Bitcoin to my neighbour or to someone on the other side of the world.

4.) Secure: Cryptocurrency funds are locked in a public key cryptography system. Only the owner of the private key can send cryptocurrency. Strong cryptography and the magic of big numbers makes it impossible to break this scheme. A Bitcoin address is more secure than Fort Knox.

5.) Permissionless: You dont have to ask anybody to use cryptocurrency. Its just a software that everybody can download for free. After you installed it, you can receive and send Bitcoins or other cryptocurrencies. No one can prevent you. There is no gatekeeper.

1.) Controlled supply: Most cryptocurrencies limit the supply of the tokens. In Bitcoin, the supply decreases in time and will reach its final number some time around the year 2140. All cryptocurrencies control the supply of the token by a schedule written in the code. This means the monetary supply of a cryptocurrency in every given moment in the future can roughly be calculated today. There is no surprise.

2.) No debt but bearer: The Fiat-money on your bank account is created by debt, and the numbers, you see on your ledger represent nothing but debts. Its a system of IOU. Cryptocurrencies dont represent debts. They just represent themselves. They are money as hard as coins of gold.

To understand the revolutionary impact of cryptocurrencies you need to consider both properties. Bitcoin as a permissionless, irreversible and pseudonymous means of payment is an attack on the control of banks and governments over the monetary transactions of their citizens. You cant hinder someone to use Bitcoin, you cant prohibit someone to accept a payment, you cant undo a transaction.

As money with a limited, controlled supply that is not changeable by a government, a bank or any other central institution, cryptocurrencies attack the scope of the monetary policy. They take away the control central banks take on inflation or deflation by manipulating the monetary supply.

While its still fairly new and unstable relative to the gold standard, cryptocurrency is definitely gaining traction and will most certainly have more normalized uses in the next few years. Right now, in particular, its increasing in popularity with the post-election market uncertainty. The key will be in making it easy for large-scale adoption (as with anything involving crypto) including developing safeguards and protections for buyers/investors. I expect that within two years, well be in a place where people can shove their money under the virtual mattress through cryptocurrency, and theyll know that wherever they go, that money will be there. Sarah Granger, Author, and Speaker.

Mostly due to its revolutionary properties cryptocurrencies have become a success their inventor, Satoshi Nakamoto, didnt dare to dream ofit. While every other attempt to create a digital cash system didnt attract a critical mass of users, Bitcoin had something that provoked enthusiasm and fascination. Sometimes it feels more like religion than technology.

Cryptocurrencies are digital gold. Sound money that is secure from political influence. Money that promises to preserve and increase its value over time. Cryptocurrencies are also a fast and comfortable means of payment with a worldwide scope, and they are private and anonymous enough to serve as a means of payment for black markets and any other outlawed economic activity.

But while cryptocurrencies are more used for payment, its use as a means of speculation and a store of value dwarfs the payment aspects. Cryptocurrencies gave birth to an incredibly dynamic, fast-growing market for investors and speculators. Exchanges like Okcoin, poloniex or shapeshift enables the trade of hundreds of cryptocurrencies. Their daily trade volume exceeds that of major European stock exchanges.

At the same time, the praxis of Initial Coin Distribution (ICO), mostly facilitated by Ethereums smart contracts, gave life to incredibly successful crowdfunding projects, in which often an idea is enough to collect millions of dollars. In the case of The DAO it has been more than 150 million dollars.

In this rich ecosystem of coins and token, you experience extreme volatility. Its common that a coin gains 10 percent a day sometimes 100 percent just to lose the same at the next day. If you are lucky, your coins value grows up to 1000 percent in one or two weeks.

Follow this link:

What is Cryptocurrency: Everything You Need To Know ...

800 Gambler – Gambling Problem Hotline in NJ | Gambling …

If you or a loved one struggle with a gambling problem, there is hope. Whether you cannot seem to stop casino gambling in Atlantic City or betting on fantasy sports from the comfort of your home, treatment and support are readily available. The Council on Compulsive Gambling of New Jersey (CCGNJ) has helped countless people recover from disordered gambling since its inception. By facilitating access to various programs, services, and other resources, we work to educate the public about this disorder and provide aid to anyone who needs it.

Our free hotline 800-GAMBLER gives disordered gamblers and their loved ones confidential assistance 24/7. If you call or text this number, know that you will be treated with compassion and understanding. Reaching out for help signifies bravery and strength not weakness. If you or a loved one struggle with problem gambling, we offer support, treatment, and hope.

When someone contacts our hotline, we present them with several treatment and rehabilitation options that NJ residents can easily access.

Gamblers Anonymous

Our hotline can help people find local Gamblers Anonymous meetings near Freehold, Monmouth, Marlboro Township, or anywhere else in the state. Gamblers Anonymous meetings in New Jersey allow people to develop a supportive network of peers that have all committed to recovery from disordered gambling. Through this 12-step program, problem gamblers share strategies on how to resist their urges while celebrating each others success. Participating in Gamblers Anonymous greatly improves the chance of recovery.

In most cases, a disordered gamblers closest family members experience some emotional turmoil or trauma, as well. These people are also welcome to attend Gam-Anon meetings. By doing so, they often gain an enhanced understanding of disordered gambling and, in the process, become a better ally in their loved ones recovery.

Treatment Providers and In-Patient Facilities

Through our hotline, disordered gamblers can also find professional counselors that can help them stop their problematic behavior. Through therapy, people with this disorder can better understand the underlying factors or motivations that may have led them to behavior like excessive sports gambling in Atlantic City in the first place. Cognitive behavioral therapy techniques also help these individuals become more mindful of their thought patterns, giving them more control over their own behavior.

Sometimes, disordered gamblers may feel that they need a serious intervention. In those cases, in-patient facilities can give them the intensive treatment that they require. The patient would live at the facility as they receive structured care and therapy.

Text or Chat Options

Anyone who wants to learn how to stop gambling but would rather not call the hotline can text 800-GAMBLER or chat with a representative online, as well. Whatever your unique needs might be, we seek to accommodate you we only wish to provide help for gambling disorders (sometimes referred to as gambling addiction) in New Jersey to anyone who needs it.

As a private, non-profit organization 501(c)(3), we have dedicated ourselves to helping problem gamblers all throughout NJ. We focus on educating the general public, training professionals throughout the state, referring disordered gamblers and their families to appropriate treatment options, and advocating for increased services to help combat the rate of disordered gambling in the state.

The Council on Compulsive Gambling of New Jersey also advises the New Jersey Department of Human Services and the Division of Mental Health and Addiction Services, provides the executive and legislative branches of the state government with relevant data concerning disordered gambling, and offers assistance to private or public agencies in the state per request. The CCGNJ neither opposes nor endorses legalized gambling; however, we may take positions on various issues when they have an impact on the people we are trying to help.

Whether you live in Atlantic City, Freehold, Marlboro Township, Monmouth, or anywhere else in the state, we can help you recover from disordered gambling. Call or text our hotline, 800-GAMBLER, today.

More:

800 Gambler - Gambling Problem Hotline in NJ | Gambling ...

Lithium Orotate Nootropics Expert

Lithium helps prevent mood swings, is anti-anxiety and antidepressant, promotes neurogenesis, protects from neurodegenerative disease, and is anti-aging

Lithiumis a soft, silvery-white alkali metal so reactive (it sparks when it touches water) that its not found in nature. Instead, its found in mineral compounds and in mineral water.

Cosmologists believe that lithium was one of the 3 elements synthesized in the Big Bang.[i] So its been around for a long time.

Most of us associate lithium with treating mental illnesses like bipolar disorder and mania. Or the lithium-ion battery in our phone. Which has a tendency to blow up occasionally.

Turns out that the anti-psychotic medication lithium isnt even a drug. Its actually a mineral. And part of the same family of minerals that include potassium and sodium.

As a nootropic, micro-dosing lithium provides some amazing anti-aging benefits. Recent research shows that low-dose lithium may also help slow the progression of neurodegenerative diseases like Alzheimers, dementia and Parkinsons disease.

Low-dose lithium also helps neurogenesis and memory. And is a mood stabilizer.

Here well investigate daily or frequent use of Lithium Orotateas a nootropic, and how it benefits cognitive health.

Lithium helps:

Lithiumis an alkali mineral and one the trace elements considered essential for both animal and human reproductive health, and general health and wellness.

Discovered as a chemical element in 1817, lithiums first recorded modern medical use was in 1871 for the treatment of mania.

But the use of lithium for therapeutic use goes back to ancient Greek and Roman times. People enjoyed soaking in alkali springs to help with physical and mental illness.

People have been using mineral springs for therapeutic use ever since. Lithia Springs in Douglas County, Georgia was so popular that people came for miles just to drink the water.

The Sweet Water hotel, a luxury 500-room resort was opened in 1887. And attracted famous authors, business people and prominent politicians who came for the springs health benefits. The name Lithia stems from water rich in lithium.

Studies from around the world have shown the critical health benefits of lithium. One study using data from 27 Texas counties from 1978 1987 found that rates of suicide, homicide and rape were significantly higher in counties whose drinking water contained little or no lithium.[v]

Another study of lithium levels in tap water in 18 municipalities in Japan showed standard mortality ratios lower in places with higher lithium levels.[vi]

Yet another study conducted in Texas in 2013 confirmed the original findings in that state. Drinking water samples from 226 counties found a correlation between lithium levels and suicide rates.[vii]

Researchers who conducted meta-analyses of lithium levels and public drinking water suggested increasing lithium levels of drinking water could potentially reduce the risk of suicide, and justify administering lithium to tap water.[viii]

An article in the Lancet in 1949 by John Cade is credited for the modern medical use of lithium as an effective treatment for manic psychosis.[ix]

The United States FDA approved high dose lithium carbonate and lithium citrate in 1970 for the treatment of bipolar disorder. Carbonic acid and citric acid are mineral carriers used to transport lithium throughout your body.

Doctors also prescribe lithium off-label for treating migraines, seizure disorders and psychosis usually after other treatments have failed.

But as we dig deeper into the most recently published research on lithium, we realize this trace element is essential for optimal health and brain function.

The lithium we get from our diet prevents many neurological and psychiatric problems. Micro-dosing lithium as a nootropicwith a supplement like Lithium Orotate can help make up for the what we dont get from our food and water.

Lithium is naturally available from fish, processed meat, milk, dairy products, eggs, potatoes and vegetables. Your typical dietary intake of lithium can range from 2 600 mcg. Amounts vary depending on where the food is grown.

Lithium helps brain health and function in several ways. But two in particular stand out.

Lithium inhibits the enzyme glycogen synthase kinase-3 (GSK-3). This inhibition upregulates brain-derived neurotrophic factor (BDNF), and insulin-like growth factor-1 (IGF-1) which stimulates neural stem cells to produce new neurons in the hippocampus.[x]

When neural stem cells produce new neurons in the hippocampus, mood and memory work as designed. But a breakdown in neurogenesis results in mood disorders.

Lithium has long been known to control mania and stabilize mood in bipolar patients. But it was not generally thought of as an antidepressant. Researchers in Tel Aviv provided the first evidence that inhibiting GSK-3 exerted a rapid antidepressant effect in mice.[xi]

Another team at Howard Hughes Medical Institute in Pennsylvania showed that feeding mice chow laced with low-dose lithium for 15 days produced a dose-dependent antidepressant effect.[xii]

Lithium induced gene transcription in the hippocampus, amygdala and hypothalamus. All areas implicated in depression, anxiety, bipolar disorder, autism and schizophrenia.

Glutamate plays a major role in the synaptic plasticity needed for learning and memory.[xiii] But over-activity of glutamate on its NMDA receptors causes neuron death and is implicated in Alzheimers, Huntingtons and Parkinsons disease. Lithium inhibits this overactivity.[xiv]

Lithium also increases the production of a neuroprotective protein called bcl-2.[xv] Researchers maintain that lithium is the only medication that has been demonstrated to significantly increase bcl-2 in several brain areas.

Lithium has also recently been evaluated in preventing and treating traumatic brain injury. In a study conducted in 2014, Dr. Peter Leeds stated that lithium had demonstrated robust beneficial effects in experimental models of Traumatic Brain Injury (TBI). These include decreases in TBI-induced brain lesion, suppression of neuroinflammation, protection against blood-brain barrier disruption, normalization of behavioral deficits, and improvement of learning and memory, among others.[xvi]

In 1985, the United States EPA estimated that dietary intake of lithium from food in the USA varied from 0.6 to 3.1 mg per day.[xvii] For comparison, people who live in the Andes in Northern Argentina consume 2 to 30 mg per day, with 2 3 mg just from drinking water.[xviii]

As your dietary sodium and caffeine increases, so does lithium excretion in urine which increases your requirement for this essential trace mineral.

Your exposure to stress and toxins from things like mercury, aspartame, MSG, Bisphenol A (BPA) and other excitotoxins also raise cortisol and other stress hormones. Increasing your need for more water-soluble nutrients like B-vitamins, magnesium, zinc and lithium.

Low lithium levels are associated with

Depression and anxiety increase

Memory and learning ability decline

Insomnia increases

Sensitivity to stress and chronic pain increase

Natural healing processes decline

Adequate daily intake of lithium could help prevent many mental and neurological diseases due to this trace minerals effects on nervous system metabolism. And its anti-inflammatory and antioxidant effects.

The clinical research and studies on the neuroprotective benefits of lithium are so overwhelming, some scientists are beginning to ask why isnt everyone using lithium?

Heres a summary of how micro-dosing lithium using Lithium Orotate can benefit your brain.

The benefits of supplementing with lithium go far beyond just optimizing cognitive health. Lithium also helps decrease insulin resistance, helps in treatment of alcoholism and other addictions, supports bone health, balances your circadian rhythm and more.

My personal experience with Lithium Orotate has made me a believer in micro-dosing lithium. Im Adult ADD and deal with mood swings from time to time.

If Im going around the bend because something upset me, I take 5 mg of Lithium Orotate. Within 15 minutes my mood stabilizes and I feel normal again. Consistent use puts me in a happy mood.

Many others report youll feel the results taking a low dose of lithium quickly. But for some, the full effect can take anywhere from 1 to 3 weeks. Micro-dosing 5 10 mg of lithium daily results in consistent results within a month or two for some. Ive experienced great results within a couple of days.

So if you lash out at people in anger, and dont fully understand why you get so angry it could be your lithium levels are low.

Many neurohackers with depression and anger issues notice results quickly. Within the first couple of days you should feel more calm, relaxed, and experience less stress.

Keep in mind that lithium at any dose is not for everyone. But if you get adequate lithium from your diet and water, and still experience some of the mood swings talked about in this review, you could be dealing with other issues. You should know within a couple of hours of supplementing with low-dose lithium if this supplement is for you.

For some, Lithium Orotate means feeling excited about life for the first time in a long time. Anxiety and social anxiety are no longer a problem. Life is more fun and enjoyable.

Some say Lithium Orotate works better than any prescription that theyve ever tried to treat severe depression. It provides a nice, smooth mood balance without all the toxicity associated with mega-doses of lithium carbonate.

If youre dealing with PTSD or mild insomnia, you may want to try Lithium Orotate. Focus could improve, racing thoughts diminish and motivation levels could increase. Youll have more coping ability.

A study at McMaster University in Canada set out to determine the effects on hippocampus volume in 14 bipolar patients who received lithium therapy.

The researchers examined the effects of lithium on hippocampal volumes and memory performance and recall over 2 4 years. The patients had not received any type of medication prior to using lithium.

The study found increases in hippocampus volume over time. And evidence of improvement of verbal memory performance over the 4-year measurement period.

The researchers concluded that the results of the study were consistent with the literature stating the neuroprotective effects of lithium. And that long-term treatment of lithium is associated with preservation of memory and recall due to increased hippocampus size.[xxi]

24 adults recovering from heroin or methamphetamine addiction participated in a study in San Diego. Group A received 400 mcg per day of lithium taken orally for 4 weeks. The placebo Group B naturally took a non-active placebo.

Subjects completed a mood test questionnaire containing questions about their ability to think, work, mood and emotions. For the lithium group, mood test scores increased steadily and significantly during the 4 week period.

The lithium group also reported significantly increased levels of happiness, friendliness and energy. Group B showed no improvement during the same period.

The researchers concluded that low-dose lithium provided a mood-improving and stabilizing effect.[xxii]

In this study, 42 alcoholic patients were treated with Lithium Orotate during alcohol rehabilitation in a private clinical setting for six months. The data was collected from clinical practice records for the 10 years following the initial study.

The patients received 150 mg of Lithium Orotate daily for six months along with calcium orotate, magnesium orotate, bromelain and essential phospholipids.

Ten of the patients had no relapse from 3 10 years. 13 patients stayed sober from 1 3 years. The remaining patients relapsed between 6 12 months.

The researchers concluded that Lithium Orotate therapy was safe in treating addiction with minor adverse side effects.[xxiii]

Lithium retains a grim and undeserved reputation. Likely because it was originally associated with serious mental illness. And like most medications, lithium can produce serious side effects if not monitored properly.

Lithium carbonate or lithium chloride salts are typically prescribed for long-term control of bipolar disorder at 900 1200 mg per day. The major problem with such high doses of lithium are some very serious and debilitating side effects.

For nootropic use, we suggest Lithium Orotate which typically contains only 5 mg of elemental lithium. Lithium Orotate is orotic acid combined with lithium.

Orotic acid reportedly makes the lithium more bioavailable than lithium carbonate. The lithium is released once it crosses the blood-brain barrier. So youll get the benefits of lithium supplementation while avoiding the toxic side effects of high doses.[xxiv]

Lithium Orotate recommended dose is 5 mg two or three times per day. See Available Forms for more on lithium amounts in nootropic supplements.

Many neurohackers use Lithium Orotate only as needed. For example, when feeling anxious or in the middle of a mood swing.

For someone with bipolar disorder or manic disorders, increasing to two 5 mg tablets up to 3-times per day may be more effective.

Naturopathic doctors suggest stacking 1,000 mg of Omega-3 and 400 UI of Vitamin E (as mixed tocopherols) each day youre using Lithium Orotate.

Do not confuse Lithium Orotate with lithium carbonate. The carbonate version of lithium is only available by prescription and comes with a host of side effects.

Lithium Orotate at low doses is non-toxic and lab tests are not required to monitor your lithium levels because it does not show up in blood samples.

Lithium Orotate should not be used if you are dealing with significant renal or cardiovascular disease, severe dehydration or sodium depletion, or if youre taking diuretics or ACE inhibitors.

Do not use Lithium Orotate if you are pregnant or breast-feeding.

You should check with your doctor if you are on any medication before using Lithium Orotate.

Mother Nature has already put the antipsychotic drug lithium in drinking water. And you get some lithium from food depending on where its grown.

Supplemental Lithium Orotate typically comes in 120 or 130 mg capsules or tablets containing 5 mg of elemental lithium.

Lithium Orotate 5 mg 2 or 3 times per day.

We recommend using Lithium Orotate as anootropic supplement if youre feeling anxious or depressed. Or experiencing mood swings.

Your bodydoes notmake lithium on its own. So you must get this essential trace mineral from your diet, or a supplement like Lithium Orotate.

Lithium combined with orotic acid makes Lithium Orotate which readily crosses theblood-brain barrier, and you should feel its effects within 15 20 minutes of taking it.

Lithium Orotate is especially effective if youre feeling stressed, or mentally over-worked. Your brain uses lithium faster and it needs to be replaced. Which you can do by using Lithium Orotate.

Lithium Orotate is great if you are ADHD because lithium calms the hyperactivity in your brain.

Supplementing with lithium does not change your state of consciousness. It simply helps bring you back to feeling normal and happy.

We suggest trying Lithium Orotate as a nootropic supplement with your first dose at 5 mg and see how you react. If you experience no negative reaction, try another 5 mg in a few hours. Up to 3 5 mg doses per day.

Youll likely experience the full benefits of Lithium Orotate within a week of consistent use.

REFERENCES

[i] Boesgaard A.M., Steigman G. (1985). "Big bang nucleosynthesis Theories and observations". Annual Review of Astronomy and Astrophysics. Palo Alto, CA. 23: 319378. (source)

[ii] Swann A.C. Norepinephrine and (Na+, K+)-ATPase: evidence for stabilization by lithium or imipramine. Neuropharmacology. 1988 Mar;27(3):261-7. (source)

[iii] Herbert V., Colman N. Release of vitamin binding proteins from granulocytes by lithium: vitamin B12 and folate binding proteins. Advances in Experimental Medicine and Biology. 1980;127:61-78. (source)

Visit link:

Lithium Orotate Nootropics Expert

Plumber & HVAC Des Moines IA | Golden Rule Plumbing …

Golden Rule Plumbing, Heating & Cooling has proudly served Des Moines, IA and the rest of the Des Moines area for more than two decades. We attribute our success to our firm belief that the customer always comes first no matter what. When you contact us for plumbing services, repairs for your air conditioning or heating system, or a new installation for a water heater (and these are only a few of our many services), you can count on work from skilled professionals who use the best current technology to see that every job is done rightand done right the first time.

Our services cover an immense range of types of work: plumbing, drain and sewer line cleaning, HVAC services, geothermal installation and repair, plus plumbing and HVAC for commercial buildings and properties. We back up our work with a 100% satisfaction guarantee, and our upfront pricing ensures that youll always know the cost before we start any job. You can reach us 24 hours a day when you need emergency services.

We offer a full range of residential plumbing services in Des Moines, IA. This includes everything from a simple drain unclogging to a large wholehouse repiping. Your household plumbing is vital for everyday convenience and comfort, and youll only want to trust plumbers with the experience necessary to ensure an excellent job each time. We have the plumbing professionals who can deliver!

Des Moines experiences extremes in weather over the year, so its imperative that homes have heating and air conditioning systems able to handle the temperature swings. When you rely on an HVAC contractor with more than 20 years of experience in Des Moines, you can relax knowing that whatever heating and AC services you require will be done right. We install a wide variety of systems, as well as provide repairs, replacements, and maintenance.

We take pride that one of our specialties is work with geothermal systems. You might think using geothermal heating and cooling is out of reach for your house, but our experienced professionals would love to show you otherwise! We want to help more homes enjoy the energysaving and environmentallyfriendly benefits of using geothermal power. Our team installs, replaces, maintains, and repairs geothermal heat pumps in the area. Call to find out more.

When plumbing problems occur at a business, its a bigger emergency than when they occur in a residential building. Many people depend on the plumbing, and the bottom line can be affected if the trouble isnt solved fast. Golden Rule Plumbing, Heating & Cooling offers commercial plumbing work in Des Moines, IA to repair any problem, and we also install and maintain commercial plumbing equipment. We have you covered for commercial HVAC services as well!

Our motto is"We Obey the Rules to Live By!".

View post:

Plumber & HVAC Des Moines IA | Golden Rule Plumbing ...

Freedom Of Speech Quotes (305 quotes)

Until every soul is freely permitted to investigate every book, and creed, and dogma for itself, the world cannot be free. Mankind will be enslaved until there is mental grandeur enough to allow each man to have his thought and say. This earth will be a paradise when men can, upon all these questions differ, and yet grasp each other's hands as friends. It is amazing to me that a difference of opinion upon subjects that we know nothing with certainty about, should make us hate, persecute, and despise each other. Why a difference of opinion upon predestination, or the trinity, should make people imprison and burn each other seems beyond the comprehension of man; and yet in all countries where Christians have existed, they have destroyed each other to the exact extent of their power. Why should a believer in God hate an atheist? Surely the atheist has not injured God, and surely he is human, capable of joy and pain, and entitled to all the rights of man. Would it not be far better to treat this atheist, at least, as well as he treats us?

Christians tell me that they love their enemies, and yet all I ask isnot that they love their enemies, not that they love their friends even, but that they treat those who differ from them, with simple fairness.

We do not wish to be forgiven, but we wish Christians to so act that we will not have to forgive them. If all will admit that all have an equal right to think, then the question is forever solved; but as long as organized and powerful churches, pretending to hold the keys of heaven and hell, denounce every person as an outcast and criminal who thinks for himself and denies their authority, the world will be filled with hatred and suffering. To hate man and worship God seems to be the sum of all the creeds. Robert G. Ingersoll, Some Mistakes of Moses

Excerpt from:

Freedom Of Speech Quotes (305 quotes)

Timeline of space exploration – Wikipedia

DateMission successCountry/organizationMission name12 April 1981First Reusable manned spacecraft (orbital) USA (NASA)STS-11 March 1982First Venus soil samples and sound recording of another world USSRVenera 1325 January 1983First Infrared orbital observatory USA (NASA) UK (SERC) Netherlands (NIVR)IRAS13 June 1983First spacecraft beyond the orbit of Neptune (first spacecraft to pass beyond all Solar System planets) USA (NASA)Pioneer 107 February 1984First untethered spacewalk, Bruce McCandless II USA (NASA)STS-41-B24 January 1986First Uranus flyby (closest approach 81,500 kilometers (44,000nmi) USA (NASA)Voyager 228 January 1986First major American space loss, the Space Shuttle Challenger disaster, an explosion soon after liftoff which killed, among others, Christa McAuliffe, a high school teacher USA (NASA)STS-51-L19 February 1986First consistently inhabited long-term research space station USSRMir8 August 1989First astrometric satellite ESAHipparcos25 August 1989First Neptune flyby (closest approach at 29,240km) USA (NASA)Voyager 218 November 1989First orbital cosmic microwave observatory USA (NASA)COBE14 February 1990First photograph of the whole Solar System[7] USA (NASA)Voyager 124 April 1990Optical orbital observatory USA (NASA) ESAHubble Space Telescope15 September 1990Extended (multi-year) orbital exploration of Venus USA (NASA)Magellan21 October 1991First asteroid flyby (951 Gaspra closest approach 1,600 kilometers) USA (NASA)Galileo8 February 1992First polar orbit around the Sun USA (NASA) ESAUlysses22 March 1995Record longest duration spaceflight (437.7 days) set by Valeri Polyakov Russia (FKA)Mir7 December 1995First orbit of Jupiter USA (NASA)Galileo7 December 1995First mission into the atmosphere of a gas giant (Jupiter) USA (NASA)Galileo's atmospheric entry probe12 February 1997First orbital radio observatory Japan (ISAS)HALCA4 July 1997First operational rover on another planet (Mars) USA (NASA)Mars Pathfinder20 November 1998First multinational space station, Largest man-made object built in space to date Russia(FKA) USA (NASA) Europe (ESA) Japan (JAXA) Canada (CSA)International Space Station14 February 2000First orbiting of an asteroid (433 Eros) USA (NASA) ESANEAR Shoemaker12 February 2001First landing on an asteroid (433 Eros) USA (NASA)NEAR Shoemaker1 July 2004First orbit of Saturn USA (NASA) ESA Italy (ASI)CassiniHuygens8 September 2004First sample return beyond lunar orbit (solar wind) USA (NASA)Genesis14 January 2005First soft landing on Titan ESA USA (NASA) Italy (ASI)CassiniHuygens19 November 2005First asteroid ascent (25143 Itokawa)First interplanetary escape without undercarriage cutoff Japan (JAXA)Hayabusa15 January 2006First sample return from comet (81P/Wild) USA (NASA)Stardust6 March 2009Kepler Mission is launched, first space telescope designated to search for Earth-like exoplanets[8] USA (NASA)Kepler Mission13 June 2010First sample return from asteroid (25143 Itokawa) Japan (JAXA)Hayabusa18 March 2011First orbit of Mercury USA (NASA)MESSENGER16 July 2011First orbit of giant asteroid Vesta USA (NASA)Dawn25 August 2012First manmade probe in interstellar space. USA (NASA)Voyager 112 November 2014First man-made probe to make a planned and soft landing on a comet (67P/ChuryumovGerasimenko).[9] ESARosetta6 March 2015First orbit of dwarf planet (Ceres).First spacecraft to orbit two separate celestial bodies. USA (NASA)DawnJuly 2015First flyby of dwarf planet (Pluto).Last original encounter with one of the nine major planets recognized in 1981. USA (NASA)New Horizons10 August 2015Lettuce was the first food eaten that was grown in space.[10] USA (NASA) Japan (JAXA)International Space Station21 December 2015The first propulsive landing for an orbital rocket. USA (SpaceX)Falcon 9 first-stage landing tests

View post:

Timeline of space exploration - Wikipedia

Amazon Aurora Fast Database Cloning | AWS News Blog

Today, I want to quickly show off a feature of Amazon Aurora that I find incredibly useful: Fast Database Cloning. By taking advantage of Auroras underlying distributed storage engine youre able to quickly and cheaply create a copy-on-write clone of your database.

In my career Ive frequently spent time waiting on some representative sample of data to use in development, experiments, or analytics. If I had a 2TB database it could take hours just waiting for a copy of the data to be ready before I could peform my tasks. Even within RDS MySQL, I would still have to wait several hours for a snapshot copy to complete before I was able to test a schema migration or perform some analytics. Aurora solves this problem in a very interesting way.

The distributed storage engine for Aurora allows us to do things which are normally not feasible or cost-effective with a traditional database engine. By creating pointers to individual pages of data the storage engine enables fast database cloning. Then, when you make changes to the data in the source or the clone, a copy-on-write protocol creates a new copy of that page and updates the pointers. This means my 2TB snapshot restore job that used to take an hour is now ready in about 5 minutes and most of that time is spent provisioning a new RDS instance.

The time it takes to create the clone is independent of the size of the database since were pointing at the same storage. It also makes cloning a very cost-effective operation since I only pay storage costs for the changed pages instead of an entire copy. The database clone is still a regular Aurora Database Cluster with all the same durability guarentees.

Lets clone a database. First, Ill select an Aurora (MySQL) instance and select create-clone from the Instance Actions.

Next Ill name our clone dolly-the-sheep and provision it.

It took about 5 minutes and 30 seconds for my clone to become available and I started making some large schema changes and saw no performance impact. The schema changes themselves completed faster than they would have on traditional MySQL due to improvements the Aurora team made to enable faster DDL operations. I could subsequently create a clone-of-a-clone or even a clone-of-a-clone-of-a-clone (and so on) if I wanted to have another team member perform some tests on my schema changes while I continued to make changes of my own. Its important to note here that clones are first class databases from the perspective of RDS. I still have all of the features that every other Aurora database supports: snapshots, backups, monitoring and more.

I hope this feature will allow you and your teams to save a lot of time and money on experimenting and developing applications based on Amazon Aurora. You can read more about this feature in the Amazon Aurora User Guide and I strongly suggest following the AWS Database Blog. Anurag Guptas posts on quorums and Amazon Aurora storage are particularly interesting.

Have follow-up questions or feedback? Ping us at aurora-pm@amazon.com, or leave a comment here. Wed love to get your thoughts and suggestions.

Randall

Continued here:

Amazon Aurora Fast Database Cloning | AWS News Blog